Significant Ownership of DME Capital Management, LP
- Notable people
- David Einhorn
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for DME Capital Management, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Daniel Roitman - DME Advisors GP, LLC, its General Partner, by Daniel Roitman/Chief Operating Officer
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow DME Capital Management, LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from DME Capital Management, LP
Significant Ownership of DME Capital Management, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| COYA | Coya Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 9.9% | $10,783,903 | 1,651,440 | DME Advisors GP, L.L.C. | 31 Dec 2024 | ||
| CNR | Core Natural Resources, Inc. | Common Stock, par value $0.01 per share | 4.8% | $104,614,895 | 1,411,426 | DME Advisors GP, L.L.C. | 31 Dec 2024 |
Schedules 13D/G Reported by DME Capital Management, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.